[
  {
    "ts": null,
    "headline": "ResMed (RMD) Valuation Check After Strong Earnings And Dividend Update",
    "summary": "ResMed (RMD) is back in focus after reporting higher sales and net income for its second quarter and first half of fiscal 2026, alongside a fresh quarterly dividend declaration of $0.60 per share. See our latest analysis for ResMed. ResMed’s recent earnings and dividend news comes after a period of steadier trading, with a 90 day share price return of 2.98% and a 1 year total shareholder return of 10.96%. This suggests gradually building momentum rather than a sharp re rating. If this update...",
    "url": "https://finnhub.io/api/news?id=6e3252da1d3c38f9749a69b60892c56de35116e563664264c2ae9f7cdfd7092f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770894847,
      "headline": "ResMed (RMD) Valuation Check After Strong Earnings And Dividend Update",
      "id": 139054676,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "ResMed (RMD) is back in focus after reporting higher sales and net income for its second quarter and first half of fiscal 2026, alongside a fresh quarterly dividend declaration of $0.60 per share. See our latest analysis for ResMed. ResMed’s recent earnings and dividend news comes after a period of steadier trading, with a 90 day share price return of 2.98% and a 1 year total shareholder return of 10.96%. This suggests gradually building momentum rather than a sharp re rating. If this update...",
      "url": "https://finnhub.io/api/news?id=6e3252da1d3c38f9749a69b60892c56de35116e563664264c2ae9f7cdfd7092f"
    }
  },
  {
    "ts": null,
    "headline": "Is It Time To Reassess ResMed (RMD) After Recent Medical Devices Sector Interest",
    "summary": "If you are wondering whether ResMed's current share price lines up with its underlying worth, you are not alone. That is exactly what this article will unpack for you. ResMed recently closed at US$259.62, with returns of 1.3% decline over 7 days, 0.7% over 30 days, 6.0% year to date, 11.0% over 1 year, 24.3% over 3 years, and 35.7% over 5 years. This gives investors a useful backdrop before comparing price to value. Recent news flow around ResMed has largely focused on ongoing interest in...",
    "url": "https://finnhub.io/api/news?id=b5e11f423030ae6b4fdc954aa44cbca84c0e5aa09e107b986e547077841a9135",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770887810,
      "headline": "Is It Time To Reassess ResMed (RMD) After Recent Medical Devices Sector Interest",
      "id": 139053992,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "If you are wondering whether ResMed's current share price lines up with its underlying worth, you are not alone. That is exactly what this article will unpack for you. ResMed recently closed at US$259.62, with returns of 1.3% decline over 7 days, 0.7% over 30 days, 6.0% year to date, 11.0% over 1 year, 24.3% over 3 years, and 35.7% over 5 years. This gives investors a useful backdrop before comparing price to value. Recent news flow around ResMed has largely focused on ongoing interest in...",
      "url": "https://finnhub.io/api/news?id=b5e11f423030ae6b4fdc954aa44cbca84c0e5aa09e107b986e547077841a9135"
    }
  },
  {
    "ts": null,
    "headline": "3 Quality Compounders to Consider Right Now",
    "summary": "Quality compounders are well-oiled machines. Their competitive advantages allow them to make profits consistently and reinvest them into projects that generate even more profits, creating a virtuous cycle of returns.",
    "url": "https://finnhub.io/api/news?id=4e79e13de8ff51979f8a55d361239d68bff4fd51a96dfe8689b3e6ddaaa3b2c5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770871140,
      "headline": "3 Quality Compounders to Consider Right Now",
      "id": 139054621,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Quality compounders are well-oiled machines. Their competitive advantages allow them to make profits consistently and reinvest them into projects that generate even more profits, creating a virtuous cycle of returns.",
      "url": "https://finnhub.io/api/news?id=4e79e13de8ff51979f8a55d361239d68bff4fd51a96dfe8689b3e6ddaaa3b2c5"
    }
  }
]